中国食品药品监管2024,Issue(10) :58-67.DOI:10.3969/j.issn.1673-5390.2024.10.007

真实世界研究用于支持医疗器械上市后安全性评价研究进展

Research Progress of Applying Real-World Study in Post-Market Safety Evaluation of Medical Devices

黄凌 王启平 邱嘉珉 谭小玉 钟国瑞
中国食品药品监管2024,Issue(10) :58-67.DOI:10.3969/j.issn.1673-5390.2024.10.007

真实世界研究用于支持医疗器械上市后安全性评价研究进展

Research Progress of Applying Real-World Study in Post-Market Safety Evaluation of Medical Devices

黄凌 1王启平 1邱嘉珉 2谭小玉 1钟国瑞1
扫码查看

作者信息

  • 1. 海南省药物警戒中心
  • 2. 南方医科大学药学院
  • 折叠

摘要

近年来,真实世界研究(RWS)在推动医疗器械创新发展以及支持上市后监管等方面发挥越来越重要的作用.本文通过梳理国内外RWS应用于医疗器械上市后安全性评价和政策制定情况,结合海南自由贸易港RWS用于支持医疗器械上市后安全性评价的应用情况,针对RWS支持医疗器械上市后安全性评价面临的机遇与挑战,提出关于真实世界数据用于医疗器械上市后安全性评价的相关思考,为我国医疗器械安全性评价提供参考.

Abstract

In recent years,real-world study(RWS)has played an increasingly important role in promoting the innovative development of medical devices and supporting post-market safety regulation of medical devices.This article reviews the application of RWS in both international and domestic contexts for post-market safety evaluation and policy-making of medical devices.Besides,it combines with the application of RWS to support post-market safety evaluation of medical devices in the Hainan Free Trade Port.In response to the opportunities and challenges faced in applying RWS for post-market safety evaluation,this article proposes thoughts for using real-world data to enhance the post-market safety evaluation of medical devices in China.

关键词

真实世界研究/医疗器械/上市后/安全性/评价

Key words

real-world study/medical devices/post-market/safety/evaluation

引用本文复制引用

出版年

2024
中国食品药品监管
中国医药报社

中国食品药品监管

影响因子:0.099
ISSN:1673-5390
段落导航相关论文